Financieele Dagblad publishes article on Cristal Delivery (Dutch)

News

Financieele Dagblad publishes article on Cristal Delivery (Dutch)

Date: 31/05/2012

Utrecht, The Netherlands, 31 May 2012 – The Dutch financial newspaper Financieele Dagblad today published an extensive article on Cristal Delivery, the Utrecht University spin-off company active in the field of nano particle drug delivery. Please find a PDF of the article here.

News
- 2 November 2018, Maastricht, The Netherlands – Cristal Therapeutics has appointed Dr. Axel Mescheder to the role of Chief Executive Officer (CEO) with immediate effect. He will also serve as Chief Medical Officer (CMO). Read further …
- 25 October 2018 , Maastricht, The Netherlands – Cristal Therapeutics, a clinical stage pharmaceutical company developing unique nanomedicines for the treatment of cancer and other diseases, announced today the first patient has been dosed in its Phase 2 clinical trial of lead nanomedicine candidate CPC634 for patients with platinum-resistant ovarian cancer. Read further …
- 15 September 2018, Utrecht, The Netherlands – MILabs is pleased to announce that its new VECTor6 with Broadband Photon Tomography technique has received the Commercial Innovation Award at the World Molecular Imaging Congress (WMIC) in Seattle September 12th-15th, 2018. Read further …

Thuja Capital

News

Financieele Dagblad publishes article on Cristal Delivery (Dutch)